Papers

2

Total Citations

33

H-Index

2

About

Montse Ferrer is a leading researcher in health outcomes and economic evaluation, with a specialized focus on prostate cancer care. Her work bridges clinical effectiveness and patient-centered research, particularly through the use of Patient-Reported Outcome Measures (PROMs) to assess treatment impacts on quality of life. Ferrer’s major contributions include systematic reviews on the economic efficiency of localized prostate cancer treatments in Europe, as well as comparative effectiveness studies that evaluate newer modalities like robot-assisted radical prostatectomy (RARP) and intensity-modulated radiotherapy. Her 2016 systematic review on European economic evaluations has garnered 29 citations, underscoring its influence in guiding cost-effective clinical decisions. More recently, her 2023 study on PROMs, with 4 citations, highlights the growing importance of patient perspectives in treatment comparisons. Ferrer’s work is notable for integrating rigorous economic analysis with real-world patient experiences, making her research essential for clinicians, policymakers, and health economists aiming to optimize prostate cancer management. Her contributions continue to shape evidence-based practice and patient-centered care in oncology.

Research Focus

Key Achievements

2
H-Index
2
Papers
33
Total Citations
17
Avg Citations/Paper
🏆 Most Cited Paper
Economic evaluation of treatments for patients with localized prostate cancer in Europe: a systematic review
29 citations · 2016
📈 Most Prolific Year: 2016 (1 Papers)
🤝 Key Collaborators: 20
🏛 Institutions: Universitat Autònoma de Barcelona, Pompeu Fabra University

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago